COMMUNIQUÉS West-GlobeNewswire

Virbac : Déclaration d'actions et de droits de vote 03/2025
09/04/2025
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
JAAD Publishes Study on AVAVA’s Focal Point Technology™, A Breakthrough in Laser Treatments for All Skin Tones
09/04/2025
Peer-Reviewed Research Validates AVAVA’s Revolutionary Approach to Aesthetic Laser Treatments BOSTON and NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) -- AVAVA, a leader in medical aesthetics innovation, recently published [...]
Oxford Healthspan’s Primeadine® Supplement Expands U.S. Presence as a Leader in Longevity and Cell Renewal
09/04/2025
Visit Booth G24 at the Health Optimisation Summit in Austin to Learn More AUSTIN, Texas, April 09, 2025 (GLOBE NEWSWIRE) -- Oxford Healthspan , a pioneer in developing science-backed, food-derived longevity supplements [...]
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
09/04/2025
Strategic Combination Intended to Drive Advanced AI-Driven Drug Development and Expand Precision Medicine Applications Across Cancer and Neurology LOS ANGELES, April 09, 2025 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc [...]
Merit Medical Launches the Ventrax™ Delivery System
09/04/2025
Novel all-in-one retrograde aortic access delivery system supports streamlined treatment of ventricular tachycardia SOUTH JORDAN, Utah, April 09, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a [...]
Better Choice Company Regains Compliance with NYSE American Continued Listing Standards
09/04/2025
TAMPA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it received formal notice [...]
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
09/04/2025
Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 Million Q1 2025 Earnings Conference Call Scheduled for May 8, 2025 MENLO PARK, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- PacBio ( [...]
Imprivata Introduces New Advanced Analytics Solution to Deliver Key Security and Operational Insights into Enterprise Mobile Device Usage
09/04/2025
Imprivata Mobile Access Management now offers enhanced analytics to provide in-depth mobile workflow analysis to optimize resource allocation, improve user efficiency, and drive ROI of mobile initiatives WALTHAM, Mass [...]
UAV Corp and Genetic Networks Announce Strategic Collaboration to Combat Biohazards with Cutting-Edge Technology, Genetic Networks Signs MOU with UMAV
09/04/2025
MELBOURNE, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- via IBN - Fifty 1 Labs, Inc. ( OTC: FITY ) , through its wholly owned subsidiary Genetic Networks, a pioneer in genetic perturbation and drug discovery, and UAV Corp ( [...]
Privia Health Enters Arizona In Partnership with Integrated Medical Services
09/04/2025
IMS is One of the Largest Independent Multi-Specialty Practices in the State Arizona Represents 15 th State in National Primary Care-Centric Care Delivery Network ARLINGTON, Va., April 09, 2025 (GLOBE NEWSWIRE) -- [...]
IM8 Vibrante Miami: Fueling Wellness and Innovation with a Star-Studded Event
09/04/2025
David Beckham was Joined by Dr. Amy Shah, Dr. Jeremy London, Dr. James DiNicolantonio and Kendal Toole to Reinforce IM8’s Vision for Elite Wellness Accessible to All CHARLOTTE, N.C., April 09, 2025 (GLOBE NEWSWIRE) -- [...]
Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial
09/04/2025
SARASOTA, Fla., April 09, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related conditions, today announced that it [...]
Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108
09/04/2025
Sustained positive preliminary data from all completed single ascending dose (SAD) cohorts, multiple ascending dose (MAD) cohorts, and food effects crossover, further supporting the safety and tolerability of PALI-2108 [...]
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System
09/04/2025
Successful robotic navigation was achieved in every case and met the primary endpoint of the study LIBERTY ® showed a 92% reduction in radiation exposure with no adverse events reported HINGHAM, Mass., April 09, 2025 ( [...]
Arialief Supplement: Vitamins Reviews and Complaints for Neuropathic Pain
09/04/2025
HONOLULU, April 09, 2025 (GLOBE NEWSWIRE) -- Arialief is a premium dietary supplement specifically designed to target the root causes of neuropathic discomfort. Whether your symptoms include burning, tingling, numbness [...]
Glass House Brands Announces Hemp Research and Development Agreement with the University of California, Berkeley
09/04/2025
LONG BEACH, Calif. and TORONTO, April 09, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest- [...]
M6P Therapeutics to Host Virtual KOL Event to Discuss the Lysosomal Storage Disorders Treatment Landscape on April 22, 2025
09/04/2025
Discussions will focus on Pompe Disease and M6P’s S1S3 Co-expression Platform Technology ST. LOUIS, Mo., April 09, 2025 (GLOBE NEWSWIRE) -- M6P Therapeutics (“M6PT” or “the Company”), a privately held life sciences [...]
Cingulate Receives $3 Million Grant from Private Foundation to Accelerate Development of Anxiety Asset CTx-2103 (buspirone)
09/04/2025
CTx-2103 has the Potential to be the First, Once-Daily Formulation of Buspirone, one of the Most Widely Prescribed Agents in the $5.5 Billion U.S. Anxiety Market, and the $11.6 Billion Anxiety Market Worldwide Non- [...]
Grace Therapeutics Announces Alignment with the FDA Supporting the Planned NDA Submission for GTx-104
09/04/2025
NDA Submission Anticipated Q2 Calendar 2025 PRINCETON, N.J., April 09, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx- [...]

Pages